Movement of Dental Implants During Osseointegration
MOVs-OI
Do Dental Implants Move During Osseointegration? A Prospective Multicenter Clinical Study Using Intraoral Scan Superimposition and Stability Analysis.
1 other identifier
observational
100
1 country
3
Brief Summary
Prospective multicenter observational study assessing whether dental implants undergo three-dimensional positional change between placement (T0) and pre-loading after osseointegration (T1). Two intraoral scans (STL) will be superimposed to quantify linear (mm) and angular (degrees) displacement. Clinical variables include insertion torque, primary and secondary ISQ, anatomical site, placement timing, operator-perceived bone density (Lekholm \& Zarb), bruxism, and night guard use. The primary endpoint is the 3D displacement at \~3-4 months. Multivariable analyses will explore associated factors.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2026
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 9, 2025
CompletedFirst Posted
Study publicly available on registry
December 22, 2025
CompletedStudy Start
First participant enrolled
January 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
October 1, 2027
December 22, 2025
December 1, 2025
1.2 years
December 9, 2025
December 9, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
3D positional change (linear and angular) from T0 to T1
Linear displacement (mm) and angular change (degrees) assessed by superimposing post-surgical (T0) and pre-loading (T1) intraoral STL scans using certified software.
3-4 months post-placement (pre-loading visit).
Secondary Outcomes (4)
Change in implant stability (ISQ2 vs. ISQ1)
3-4 months after implant placement (pre-loading visit).
Association between 3D displacement and insertion torque
3-4 months after implant placement.
Proportion of implants with linear displacement >0.15 mm
3-4 months after implant placement.
Influence of anatomical, surgical, and patient-related variables on 3D displacement
3-4 months after implant placement.
Study Arms (1)
Adults receiving a single dental implant
Consecutive adults indicated for a single implant-supported restoration treated in three private clinics in Spain. Care follows standard practice; no investigational interventions are mandated. The exposure of interest is the osseointegration period between implant placement (T0) and pre-loading (T1, \~3-4 months). At T0 and T1, intraoral scans (STL) are acquired and rigidly superimposed with certified software to quantify 3D positional change (linear, mm; angular, degrees). Clinical variables recorded include insertion torque, ISQ1/ISQ2, anatomical site (jaw/region), placement timing (immediate/delayed), operator-perceived bone density, and bruxism/night-guard use. Analyses are performed at the implant level (one implant per participant).
Eligibility Criteria
Consecutive adult patients in good general health who require a single dental implant-supported restoration in private clinical practice. Participants will be recruited from three collaborating dental clinics in Spain (Alicante, Murcia, and Tenerife). All candidates will be screened according to inclusion and exclusion criteria and will receive standard implant therapy under routine clinical conditions. Each participant contributes one implant, which constitutes the analytical unit of the study.
You may qualify if:
- Adults aged 18 years or older.
- Indication for a single implant-supported restoration.
- Good general health and absence of active periodontal disease.
- Willingness to provide written informed consent and to undergo two intraoral scans (immediately after implant placement - T0 - and before prosthetic loading - T1).
You may not qualify if:
- Uncontrolled systemic disease or any medical condition contraindicating implant surgery.
- High-risk antiresorptive therapy (e.g., intravenous bisphosphonates or denosumab).
- Pregnancy or breastfeeding, if applicable to local policy.
- Inability to attend the T1 follow-up visit or contraindication to intraoral scanning (e.g., limited mouth opening, severe gag reflex).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
Clínica Dental Esteve
Alicante, Alicante, 03001, Spain
Clínica Dental Sánchez Nicolás
Cabezo de Torres, Murcia, 30110, Spain
Clínica Dental García Marí
Santa Cruz de Tenerife, Tenerife, 38006, Spain
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Guillem Esteve-Pardo, PhD
CONTACT
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PhD
Study Record Dates
First Submitted
December 9, 2025
First Posted
December 22, 2025
Study Start
January 1, 2026
Primary Completion (Estimated)
April 1, 2027
Study Completion (Estimated)
October 1, 2027
Last Updated
December 22, 2025
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF
- Time Frame
- IPD will be available beginning 6 months after publication of the primary results and for a minimum of 5 years thereafter.
- Access Criteria
- Qualified researchers affiliated with academic or non-profit institutions may request access to de-identified implant-level and patient-level data, the data dictionary, and the main analysis code. Requests must include a brief research proposal and be submitted in writing to the study sponsor (Clínica Dental Esteve, S.L.). The principal investigator will review each request for scientific merit and ethical compliance. Approved users will sign a data use agreement and receive secure, time-limited access through an encrypted repository managed by the sponsor.
De-identified implant-level and patient-level data will be made available upon reasonable request after publication of the main study results. Shared materials will include the full dataset (excluding any directly identifying information), the data dictionary, and the main statistical analysis code. Access requests must be submitted in writing to the study sponsor (Clínica Dental Esteve, S.L.) and will be reviewed by the principal investigator to ensure compliance with ethical and privacy regulations. Data will be provided through a secure repository or encrypted transfer.